News from menarini silicon biosystems A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Dec 10, 2020, 08:16 ET DETECT program studies validate clinical relevance of CTC HER2 phenotypes in metastatic breast cancer patients with HER2 negative primary tumor and positive impact of reference anti-HER2 treatment on overall survival

Menarini Silicon Biosystems, a pioneer of liquid biopsy technology, announced today new data from the DETECT study program. These data focused on...


Dec 09, 2020, 09:06 ET New Global Pooled Analysis Supports Clinical Utility of Circulating Tumor Cell Count for Early Monitoring of Metastatic Breast Cancer

Menarini Silicon Biosystems, a pioneer of liquid biopsy technology, today announced the results of a pooled analysis of 14 clinical trials on the...


Nov 09, 2020, 02:00 ET New Research Study Supports Clinical Utility of Circulating Tumor Cell Count for Metastatic Breast Cancer

Menarini Silicon Biosystems, the pioneer of liquid biopsy technology, today announced the publication of a research study providing support for the...


Aug 04, 2020, 09:15 ET Two Studies Presented at AACR Meeting Deepen Understanding Of Cancer Mechanisms

Menarini Silicon Biosystems, the pioneer of liquid biopsy technology, today announced two new studies describing genetic changes in circulating...


Jul 13, 2020, 08:30 ET Menarini Silicon Biosystems se asocia con OpGen para ampliar la distribución de la plataforma CELLSEARCH en Norteamérica

Menarini Silicon Biosystems (MSB), el pionero de las tecnologías de biopsia líquida y célula rara, anunció hoy que ha establecido una asociación...


Jul 13, 2020, 08:30 ET Menarini Silicon Biosystems Partners with OpGen to Broaden Distribution of CELLSEARCH Platform in North America

Menarini Silicon Biosystems (MSB), the pioneer of liquid biopsy and rare cell technologies, announced today that it has entered into a strategic...


Jun 10, 2020, 08:15 ET Menarini Silicon Biosystems Begins Distribution of Rapid COVID-19 Antibody Test in North America

Menarini Silicon Biosystems, the pioneer of liquid biopsy and rare cell technologies, announced today that it has signed a non-exclusive distribution ...


Jun 09, 2020, 08:10 ET New ASCO Studies Offer Evidence for Use of Circulating Tumor Cells as a Prognostic Biomarker for Advanced Prostate and Breast Cancer

Menarini Silicon Biosystems, the pioneer of liquid biopsy and single cell technologies, announced today that results from a new study presented at...


Apr 27, 2020, 08:10 ET Menarini Silicon Biosystems Explores New Application for Circulating Endothelial Cells in COVID-19

Menarini Silicon Biosystems, a global leader in liquid biopsy and rare cells technologies, today announces that it is exploring the possible use of...


Feb 27, 2020, 08:15 ET Menarini Silicon Biosystems to Announce New Solutions for Advancing Liquid Biopsy in Clinical Research

Menarini Silicon Biosystems, the pioneer of liquid biopsy and rare cell technologies, announced today that it is developing several new products that ...


Dec 09, 2019, 13:05 ET New Menarini CELLSEARCH Studies to be Presented at San Antonio Breast Cancer Symposium

Menarini Silicon Biosystems, the pioneer of liquid biopsy and rare cell technologies, announced today that new research utilizing the company's...


Oct 30, 2019, 08:12 ET Menarini Silicon Biosystems to Debut VRNxT Technology at 25th Annual Meeting of the Association for Molecular Pathology

Menarini Silicon Biosystems, the pioneer of liquid biopsy and rare cell technologies, will debut the new VRNxT™ volume reduction instrument at the...


Sep 23, 2019, 08:15 ET Menarini Silicon Biosystems to Host ESMO Symposium on Clinical Importance of Circulating Tumor Cells

Menarini Silicon Biosystems, the pioneer of liquid biopsy and rare cell technologies, will host a symposium on the importance of liquid biopsy and...


Sep 19, 2019, 08:15 ET Menarini Silicon Biosystems Launches the MSBiosuite Bioinformatic Platform, Partners with BlueBee

Menarini Silicon Biosystems today announces the launch of the MSBiosuite, a cloud-based data analysis solution that completes the company workflow*...


Jul 17, 2019, 08:15 ET Menarini Silicon Biosystems Launches VRNxT Volume Reduction Instrument

Menarini Silicon Biosystems, the pioneer of liquid biopsy and rare cell technologies, announced that it will launch the new VRNxT™, a volume...


Jun 18, 2019, 08:10 ET Menarini Silicon Biosystems Introduces Use of DEPArray System for Challenging Flow Cytometry Applications at CYTO Congress

Menarini Silicon Biosystems, the pioneer of liquid biopsy and single cell technologies, will introduce its latest developments of the DEPArray™...


May 28, 2019, 08:10 ET CELLSEARCH Studies at ASCO Show Potential Predictive Role for Circulating Tumor Cells in Metastatic Breast Cancer

Menarini Silicon Biosystems, the pioneer of liquid biopsy and single cell technologies, announced today that two studies using the company's...


Mar 26, 2019, 08:15 ET New CellSearch Data To Be Presented at AACR Deepens Understanding of Metastatic Breast Cancer

Menarini Silicon Biosystems, the pioneer of liquid biopsy technology, today announced that significant advances in research using the company's...


Mar 05, 2019, 08:15 ET Menarini Silicon Biosystems Develops New Assay Workflow for Circulating Multiple Myeloma Cells

Menarini Silicon Biosystems, the pioneer of liquid biopsy technology, announced today that it will introduce a new semi-automated assay workflow...


Nov 29, 2018, 08:11 ET New Studies Using CELLSEARCH Circulating Tumor Cell Test to be Featured at San Antonio Breast Cancer Symposium

Menarini Silicon Biosystems announced today that new data utilizing the company's CELLSEARCH® Circulating Tumor Cell Test will be presented at the...


Nov 27, 2018, 08:15 ET Single-Cell Genomic Analysis of Blood Cancers to be Highlighted at American Society of Hematology Meeting

Menarini Silicon Biosystems announced today that new hem-oncology research utilizing the company's DEPArray™ single-cell isolation technology will be ...


Oct 29, 2018, 08:15 ET Menarini Silicon Biosystems Introduces New DEPArray SamplePrep Kit for Analysis of FFPE Tissue Samples

Menarini Silicon Biosystems announced today that it will launch the DEPArray™ FFPE SamplePrep Kit at the upcoming annual meeting of the Association...


May 30, 2018, 09:02 ET Les cellules tumorales circulantes vont permettre de stadifier le cancer du sein métastatique, d'après une nouvelle recherche qui sera présentée à la réunion annuelle de l'ASCO

Menarini Silicon Biosystems a annoncé aujourd'hui qu'une nouvelle étude a déterminé que l'utilisation des cellules tumorales circulantes (CTC), une...


May 30, 2018, 05:02 ET CTC ayudará con el cáncer de mama metastático, investigación nueva destacada en la reunión anual de ASCO

Menarini Silicon Biosystems anunció hoy que un nuevo estudio ha demostrado que el uso de células tumorales circulantes (CTC), un tipo de biopsia...


May 30, 2018, 05:02 ET Circulating Tumor Cells To Help Stage Metastatic Breast Cancer, New Research To Be Featured at ASCO Annual Meeting

Menarini Silicon Biosystems announced today that a new study has found that using circulating tumor cells (CTCs), a form of liquid biopsy, holds...